skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Cancer Chemotherapy And Pharmacology remover assunto: Pharmacology. Drug Treatments remover Medical Sciences remover Female remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors
A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors

Raez, Luis E. ; Papadopoulos, Kyriakos ; Ricart, Alejandro D. ; Chiorean, E. Gabriella ; DiPaola, Robert S. ; Stein, Mark N. ; Rocha Lima, Caio M. ; Schlesselman, James J. ; Tolba, Khaled ; Langmuir, Virginia K. ; Kroll, Stewart ; Jung, Donald T. ; Kurtoglu, Metin ; Rosenblatt, Joseph ; Lampidis, Theodore J.

Cancer chemotherapy and pharmacology, 2013-02, Vol.71 (2), p.523-530 [Periódico revisado por pares]

Berlin/Heidelberg: Springer-Verlag

Texto completo disponível

Citações Citado por
2
A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors

Sandhu, Shahneen K. ; Papadopoulos, Kyri ; Fong, Peter C. ; Patnaik, Amita ; Messiou, Christina ; Olmos, David ; Wang, George ; Tromp, Brenda J. ; Puchalski, Thomas A. ; Balkwill, Frances ; Berns, Birge ; Seetharam, Shobha ; de Bono, Johann S. ; Tolcher, Anthony W.

Cancer chemotherapy and pharmacology, 2013-04, Vol.71 (4), p.1041-1050 [Periódico revisado por pares]

Berlin/Heidelberg: Springer-Verlag

Texto completo disponível

Citações Citado por
3
Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer
Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer

Togashi, Yosuke ; Masago, Katsuhiro ; Masuda, Satohiro ; Mizuno, Tomoyuki ; Fukudo, Masahide ; Ikemi, Yasuaki ; Sakamori, Yuichi ; Nagai, Hiroki ; Kim, Young Hak ; Katsura, Toshiya ; Mishima, Michiaki

Cancer chemotherapy and pharmacology, 2012-09, Vol.70 (3), p.399-405 [Periódico revisado por pares]

Berlin/Heidelberg: Springer-Verlag

Texto completo disponível

Citações Citado por
4
Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial
Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial

Welsh, J. L. ; Wagner, B. A. ; van’t Erve, T. J. ; Zehr, P. S. ; Berg, D. J. ; Halfdanarson, T. R. ; Yee, N. S. ; Bodeker, K. L. ; Du, J. ; Roberts, L. J. ; Drisko, J. ; Levine, M. ; Buettner, G. R. ; Cullen, J. J.

Cancer chemotherapy and pharmacology, 2013-03, Vol.71 (3), p.765-775 [Periódico revisado por pares]

Berlin/Heidelberg: Springer-Verlag

Texto completo disponível

Citações Citado por
5
A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer
A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer

Kanai, Masashi ; Yoshimura, Kenichi ; Asada, Masanori ; Imaizumi, Atsushi ; Suzuki, Chihiro ; Matsumoto, Shigemi ; Nishimura, Takafumi ; Mori, Yukiko ; Masui, Toshihiko ; Kawaguchi, Yoshiya ; Yanagihara, Kazuhiro ; Yazumi, Shujiro ; Chiba, Tsutomu ; Guha, Sushovan ; Aggarwal, Bharat B.

Cancer chemotherapy and pharmacology, 2011-07, Vol.68 (1), p.157-164 [Periódico revisado por pares]

Berlin/Heidelberg: Springer-Verlag

Texto completo disponível

Citações Citado por
6
Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience
Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience
Material Type:
Artigo 		Adicionar ao Meu Espaço

Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience

Fine, Robert L. ; Gulati, Anthony P. ; Krantz, Benjamin A. ; Moss, Rebecca A. ; Schreibman, Stephen ; Tsushima, Dawn A. ; Mowatt, Kelley B. ; Dinnen, Richard D. ; Mao, Yuehua ; Stevens, Peter D. ; Schrope, Beth ; Allendorf, John ; Lee, James A. ; Sherman, William H. ; Chabot, John A.

Cancer chemotherapy and pharmacology, 2013-03, Vol.71 (3), p.663-670 [Periódico revisado por pares]

Berlin/Heidelberg: Springer-Verlag

Texto completo disponível

Citações Citado por
7
Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer
Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer

Stephenson, Christopher M. ; Levin, Robert D. ; Spector, Thomas ; Lis, Christopher G.

Cancer chemotherapy and pharmacology, 2013-07, Vol.72 (1), p.139-146 [Periódico revisado por pares]

Berlin/Heidelberg: Springer-Verlag

Texto completo disponível

Citações Citado por
8
A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer
A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer

Ahn, Hee Kyung ; Jung, Minkyu ; Sym, Sun Jin ; Shin, Dong Bok ; Kang, Shin Myung ; Kyung, Sun Young ; Park, Jeong-Woong ; Jeong, Sung Hwan ; Cho, Eun Kyung

Cancer chemotherapy and pharmacology, 2014-08, Vol.74 (2), p.277-282 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
9
Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis
Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis

Houk, Brett E ; Bello, Carlo L ; Poland, Bill ; Rosen, Lee S ; Demetri, George D ; Motzer, Robert J

Cancer chemotherapy and pharmacology, 2010-07, Vol.66 (2), p.357-371 [Periódico revisado por pares]

Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag

Texto completo disponível

Citações Citado por
10
Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers
Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers

Kanai, Masashi ; Imaizumi, Atsushi ; Otsuka, Yoshihiko ; Sasaki, Hiroki ; Hashiguchi, Momo ; Tsujiko, Kazu ; Matsumoto, Shigemi ; Ishiguro, Hiroshi ; Chiba, Tsutomu

Cancer chemotherapy and pharmacology, 2012, Vol.69 (1), p.65-70 [Periódico revisado por pares]

Berlin/Heidelberg: Springer-Verlag

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Assunto 

  1. Male  (2.083)
  2. Antineoplastic Agents  (1.992)
  3. Oncology  (1.975)
  4. Humans  (1.970)
  5. Life Sciences & Biomedicine  (1.956)
  6. Pharmacology & Pharmacy  (1.956)
  7. Science & Technology  (1.956)
  8. Middle Aged  (1.706)
  9. Aged  (1.579)
  10. Adult  (1.391)
  11. Cancer Research  (991)
  12. Pharmacology/toxicology  (934)
  13. Medicine  (933)
  14. Medicine & Public Health  (933)
  15. Chemotherapy  (865)
  16. Original Article  (832)
  17. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1988  (156)
  2. 1988Até1993  (290)
  3. 1994Até1999  (267)
  4. 2000Até2006  (356)
  5. Após 2006  (1.016)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.